Laurence Watts | Investor Relations, Gilmartin Group |
Benjamin Zeskind | President and Chief Executive Officer |
Brett Hall | Chief Scientific Officer |
Scott Barrett | Chief Medical Officer |
Mallory Morales | Vice President of Finance, Treasurer |
Swapnil Malekar | Piper Sandler |
Jeffrey Hung | Morgan Stanley |
Mark Breidenbach | Oppenheimer & Co. Inc. |
Michael Schmidt | Guggenheim Partners |
Welcome to the Immuneering Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this call is being recorded today, Monday, March 6, 2023.
I would now like to turn the conference over to Laurence Watts of Gilmartin Group.